Teva’s 10-year turnaround takes shape with stunning trial results
A decade has passed since Teva last delivered sensational news that sent its stock soaring by nearly 20%. The company, once known as "the people's stock" in Israel and a dominant player on the Tel Aviv Stock Exchange (TASE), had long been …